Annual report pursuant to Section 13 and 15(d)

ORGANIZATION AND DESCRIPTION OF BUSINESS (Details)

v3.22.1
ORGANIZATION AND DESCRIPTION OF BUSINESS (Details)
 12 Months Ended
Oct. 28, 2021
USD ($)
shares
Oct. 26, 2021
USD ($)
$ / shares
shares
Apr. 01, 2021
USD ($)
shares
Jan. 22, 2021
item
Dec. 31, 2021
USD ($)
$ / shares
Dec. 31, 2020
$ / shares
Business Acquisition [Line Items]            
Common stock, par value | $ / shares         $ 0.0001 $ 0.0001
Price per share | $ / shares         $ 4.00  
Proceeds from initial public offering         $ 25,378,663  
Initial public offering            
Business Acquisition [Line Items]            
Number of shares issued | shares 6,250,000          
Proceeds from initial public offering $ 28,750,000          
Conversion of convertible notes to common stock in connection with initial public offering   $ 5,106,554        
Class A common stock | Initial public offering            
Business Acquisition [Line Items]            
Number of shares issued | shares   7,187,500        
Common stock, par value | $ / shares   $ 0.0001        
Price per share | $ / shares   $ 4.00        
Proceeds from initial public offering   $ 28,750,000        
Marpai Health            
Business Acquisition [Line Items]            
Options to purchase shares of common stock | shares     1,027,602      
Warrants to purchase shares of common stock | shares     1,366,746      
Conversion ratio     1      
Convertible promissory notes acquired     $ 2,198,459      
Amount of convertible promissory notes exchanged for shares of common stock     3,800,000      
Continental Benefits            
Business Acquisition [Line Items]            
Number of healthcare subsidiaries | item       2    
Minimum cash on hand required at the time of closing of Acquisition     4,762,000      
Debt at the time of closing of Acquisition     $ 0